Literature DB >> 4935774

Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.

J K Luce, J F Gamble, H E Wilson, R W Monto, B L Isaacs, R L Palmer, C A Coltman, J S Hewlett, E A Gehan, E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4935774     DOI: 10.1002/1097-0142(197108)28:2<306::aid-cncr2820280208>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  18 in total

1.  Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.

Authors:  G P Canellos; V T DeVita; R C Young; B A Chabner; P S Schein; R E Johnson
Journal:  Br J Cancer Suppl       Date:  1975-03

Review 2.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

Review 3.  Non-Hodgkin's lymphoma. I: Characterisation and treatment.

Authors:  S E O'Reilly; J M Connors
Journal:  BMJ       Date:  1992-06-27

4.  Non-Hodgkin's lymphoma in Ibadan, Nigeria.

Authors:  O A Oluboyede; W A Olaofe; G J Esan
Journal:  J Natl Med Assoc       Date:  1977-07       Impact factor: 1.798

Review 5.  [Diagnostic and therapeutic procedures in Hodgkin's disease].

Authors:  D Huhn; C Steidle
Journal:  Blut       Date:  1973-08

6.  [Clinical manifestation and chemotherapy in Hodgkin's disease].

Authors:  C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

7.  Histiocytic medullary reticulosis in two Chinese women.

Authors:  R L Bick; T Adams
Journal:  West J Med       Date:  1974-02

8.  Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.

Authors:  G Bonadonna; M De Lena; A Lattuada; F Milani; S Monfardini; G Beretta
Journal:  Br J Cancer Suppl       Date:  1975-03

Review 9.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 10.  Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.

Authors:  James J Steinhardt; Ronald B Gartenhaus
Journal:  Clin Cancer Res       Date:  2012-06-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.